Wegovy and Ozempic both contain semaglutide as the main ingredient, but they are approved for different reasons
It prevents cellular damage by detoxifying reactive drug metabolites, enhances drug elimination, and contributes to the overall safety of therapeutic agents
Benefits of GLP-1 therapy: Non-invasive Average weight loss: 1020% (depending on medication) Improved blood sugar control, lower cholesterol, and reduced cardiovascular risk Some patients achieve remission of type 2 diabetes Common side effects: Nausea, vomiting, diarrhea, constipation Rare gallbladder or pancreas-related issues Possible muscle loss if weight loss happens too quickly without proper exercise Considerations GLP-1 medications require continuous use to maintain weight loss
Samples were centrifuged at 5000 g for 30 seconds, and bead pellets washed 3 in 500 L wash buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4) before storage at 80 C until further analysis